Literature DB >> 16388888

Regulation of CD 38 expression and function by steroid hormones in myometrium.

Soner Dogan1, Deepak A Deshpande, Thomas A White, Timothy F Walseth, Mathur S Kannan.   

Abstract

CD 38, a 45-kDa transmembrane glycoprotein, is expressed ubiquitously in many cell types, including the myometrial smooth muscle cells. CD 38 is a bifunctional protein, and has both ADP-ribosyl cyclase (cyclase) and cyclic ADP-ribose (cADPR)-hydrolase (hydrolase) activities. The cyclase converts beta-NAD to cADPR, a calcium mobilizing second messenger involved in fertilization, insulin secretion, and muscle contraction. CD 38 expression in smooth muscle is regulated by cytokines, by the steroid hormones estrogen and progesterone, and during gestation in the rat. Estrogen increases CD 38 expression, which is associated with increased cyclase, but not hydrolase, activity, indicating a differential post-translational regulation. Progesterone attenuates estrogen-induced effects on CD 38 expression and activities. This will have implications for increased calcium mobilization and contractility of the myometrium during parturition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388888     DOI: 10.1016/j.mce.2005.11.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

Review 1.  Hormonal signaling and signal pathway crosstalk in the control of myometrial calcium dynamics.

Authors:  Barbara M Sanborn
Journal:  Semin Cell Dev Biol       Date:  2007-05-18       Impact factor: 7.727

Review 2.  Roles and mechanisms of the CD38/cyclic adenosine diphosphate ribose/Ca(2+) signaling pathway.

Authors:  Wenjie Wei; Richard Graeff; Jianbo Yue
Journal:  World J Biol Chem       Date:  2014-02-26

Review 3.  CD38 and chronic lymphocytic leukemia: a decade later.

Authors:  Fabio Malavasi; Silvia Deaglio; Rajendra Damle; Giovanna Cutrona; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

Review 4.  CD38: A Potential Therapeutic Target in Cardiovascular Disease.

Authors:  Wanyun Zuo; Na Liu; Yunhong Zeng; Yaozhong Liu; Biao Li; Keke Wu; Yunbin Xiao; Qiming Liu
Journal:  Cardiovasc Drugs Ther       Date:  2021-08       Impact factor: 3.727

5.  Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-alpha and dexamethasone.

Authors:  Krishnaswamy G Tirumurugaan; Bit Na Kang; Reynold A Panettieri; Douglas N Foster; Timothy F Walseth; Mathur S Kannan
Journal:  Respir Res       Date:  2008-03-14

Review 6.  CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms.

Authors:  Deepak A Deshpande; Alonso G P Guedes; Richard Graeff; Soner Dogan; Subbaya Subramanian; Timothy F Walseth; Mathur S Kannan
Journal:  Mediators Inflamm       Date:  2018-02-07       Impact factor: 4.711

7.  CD38 Deficiency Promotes Inflammatory Response through Activating Sirt1/NF-κB-Mediated Inhibition of TLR2 Expression in Macrophages.

Authors:  Yisong Qian; Chuqiao Chen; Leliang Ma; Ziwei Wang; Ling-Fang Wang; Li Zuo; Yaqin Yang; Xiang Huang; Meixiu Jiang; Xiaolei Wang; Huidong Shi; Mingui Fu; Ke-Yu Deng; Hong-Bo Xin
Journal:  Mediators Inflamm       Date:  2018-05-27       Impact factor: 4.711

8.  Specific cyclic ADP-ribose phosphohydrolase obtained by mutagenic engineering of Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase.

Authors:  João Meireles Ribeiro; José Canales; Alicia Cabezas; Joaquim Rui Rodrigues; Rosa María Pinto; Iralis López-Villamizar; María Jesús Costas; José Carlos Cameselle
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.